info icon

Laparoscopic left hemicolectomy

OPER_JFB44

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Operations: NOMESCO codes ^JFB44

1 out of 7 registries used, show all original rules.

570

4. Check minimum number of events

None

570

5. Include endpoints

None

570

6. Filter based on genotype QC (FinnGen only)

570

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 570 262 308
Unadjusted period prevalence (%) 0.11 0.09 0.14
Median age at first event (years) 66.85 64.11 69.18

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
444
Matched controls
4438
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
+∞
323.0
444
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
187.5
233.8
229
25
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
173.5
190.9
190
19
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
125.4
155.2
161
20
L01BC06
ATC
capecitabine; oral
23.5
95.1
141
86
UJF32
NOMESCO Finland
Coloscopy
8.3
91.6
299
881
B01AB05
ATC
enoxaparin; parenteral
7.2
80.1
304
1033
130
Kela drug reimbursment
Malignant tumour
10.7
74.6
160
221
WX302
NOMESCO Finland
Thoracal epidural anesthesy
16.5
74.1
125
103
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
140.4
68.1
71
6
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
17.6
62.8
102
74
JN4BD
NOMESCO Finland
Extensive body CT
7.8
61.6
164
311
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
9.1
59.7
139
212
ZXE20
NOMESCO Finland
More than three and less than five hours
6.4
56.2
178
421
TPH07
NOMESCO Finland
Cathetrisation of artery
7.4
55.9
153
296
WX402
NOMESCO Finland
General anaesthesia
6.4
55.9
177
418
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.8
55.3
114
138
A04AA02
ATC
granisetron; systemic, transdermal
9.1
48.9
111
157
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
93.8
45.9
50
6
WZC30
NOMESCO Finland
Teaching
5.4
44.2
157
407
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
74.8
42.0
47
7
WX408
NOMESCO Finland
General anesthesy, balanced
4.2
41.7
219
834
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
154.2
40.5
42
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.3
38.2
182
622
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
207.2
37.4
38
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
87.8
36.5
40
5
H02AB02
ATC
dexamethasone; systemic
5.2
33.2
116
283
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
15.9
31.0
51
36
8140/3-C18.5
ICD-O-3
Adenocarcinoma, NOS, of splenic flexure of colon
+∞
30.6
29
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
15.0
30.4
51
38
8140/3-C18.6
ICD-O-3
Adenocarcinoma, NOS, of descending colon
166.2
30.1
31
*
C18.50
ICD-10 Finland
Malignant tumor in flexural lienalis without histology
311.3
29.1
29
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
7.2
28.7
73
118
R4110
NOMESCO Finland
Physiotherapy
3.3
27.9
187
798
ZXD10
NOMESCO Finland
Scheduled procedure
3.1
27.7
248
1299
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
49.0
26.9
32
7
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
7.4
26.3
65
100
WX290
NOMESCO Finland
Other blockade of nerve
2.9
25.1
228
1179
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.3
23.7
66
120
JFB43
NOMESCO Finland
Left hemicolectomy
39.3
21.0
26
7
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.7
20.5
61
120
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
12.5
20.1
36
31
Z2221
NOMESCO Finland
Medical doctor
2.7
19.7
172
832
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
19.2
136
575
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
18.6
217
1225
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
11.8
17.0
31
28
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
9.0
16.6
35
42
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
10.3
15.9
31
32
WX110
NOMESCO Finland
Local anesthesy
2.4
15.4
321
2328
A04AD12
ATC
aprepitant; systemic
8.5
14.3
31
39
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.6
14.1
123
575
UJF30
NOMESCO Finland
Ileoscopy through colon
3.4
13.7
69
225
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
13.1
53
144
C18.62
ICD-10 Finland
Malignant tumor of the descending colon carcinoma of the adenoma
51.6
12.9
15
*
1XC07
NOMESCO Finland
NA
51.6
12.9
15
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.2
12.0
46
119
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
48.0
11.9
14
*
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
5.6
11.8
34
65
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
9.0
11.7
24
28
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
11.5
11
*
N02BE01
ATC
paracetamol; systemic, rectal
2.7
11.2
398
3386
E0000UV
ATC
NA
2.0
11.1
184
1143
WX002
NOMESCO Finland
Sedation and analgesia
2.3
10.9
117
599
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
18.4
10.8
16
9
D75
ICPC
Malignant neoplasm colon/rectum
13.3
10.7
18
14
B01AB10
ATC
tinzaparin; parenteral
3.2
10.4
58
202
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.5
10.4
36
85
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.7
10.0
44
129
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
6.2
10.0
26
44
Z3226
NOMESCO Finland
Physiotherapist
2.3
10.0
105
531
ZX120
NOMESCO Finland
Intravenous
2.8
9.5
62
240
C18.59
ICD-10 Finland
Malignant tumor in flexura lienalis other or unspecified histology
+∞
9.4
9
*
ZXE00
NOMESCO Finland
One hour or less
1.9
9.2
193
1283
Z93.3
ICD-10 Finland
Colostomy status
10.3
9.1
17
17
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
6.3
9.0
23
38
C18.69
ICD-10 Finland
Malignant tumor of colon descendens other or unspecified histology
51.0
8.7
10
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.5
8.5
39
119
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.7
8.4
36
104
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
+∞
8.4
8
*
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
5.1
8.3
25
51
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
14.8
8.2
13
9
JN4AD
NOMESCO Finland
Body CT examination
2.8
8.2
54
209
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
8.2
62
265
A98
ICPC
Health maint/preventive medicine
3.2
7.9
425
3883
P01AB01
ATC
metronidazole; oral, rectal
1.8
7.8
181
1225
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
15.4
7.8
12
8
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
15.4
7.8
12
8
JJB71
NOMESCO Finland
Laparoscopic resection of liver
45.8
7.7
9
*
K92.1
ICD-10 Finland
Melaena
3.2
7.7
40
135
C18
ICD-10 Finland
Malignant neoplasm of colon
81.4
7.4
8
*
C18.5
ICD-10 Finland
Malignant neoplasm: Splenic flexure
81.4
7.4
8
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
7.3
59
259
L01BC59
ATC
trifluridine, combinations; systemic
30.5
7.2
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
5.8
7.1
19
34
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
5.1
7.1
21
43
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
9.5
6.8
13
14
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.5
6.8
30
90
176
Kela drug reimbursment
Regorafenib
22.9
6.7
9
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.9
6.6
20
42
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.7
6.6
27
76
Z31.5
ICD-10 Finland
Genetic counselling
3.6
6.5
28
82
UJF34
NOMESCO Finland
Left colonoscopy
8.3
6.4
13
16
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
6.3
152
1024
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
6.3
62
300
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
+∞
6.3
6
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
27.1
6.2
8
*
WX600
NOMESCO Finland
Single shot through catheter
7.8
6.2
13
17
Z3231
NOMESCO Finland
Registered nurse
1.8
6.1
130
843
Z71.8
ICD-10 Finland
Other specified counselling
1.8
6.1
107
652
JAH01
NOMESCO Finland
Laparoscopy
3.5
6.0
26
77

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
450
582
32.98
307.65
8.9
4.4
ug/l
14.0
32.6
0.62
412
488
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
203
227
13.34
176.73
6.1
3.6
u/ml
1867.7
6083.5
0.45
177
196
(3022145) Colonoscopy Study observation
281
561
8.91
151.46
1.5
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
280
712
6.76
114.23
1.8
2.4
%
20.9
22.5
1.03
274
608
(3022948) Iron [Moles/volume] in Serum or Plasma
287
825
5.99
100.17
1.8
2.4
umol/l
12.8
12.8
0.01
281
761
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
348
1186
5.97
99.58
2.5
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
391
1553
5.83
90.93
2.7
2.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
460
2183
6.74
83.98
9.5
4.9
g/l
35.9
35.2
1.99
452
2038
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
449
2259
5.65
71.26
4.2
4.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
164
425
5.01
60.84
9.7
8.9
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
143
335
5.36
59.69
10.7
9.5
%
0.6
0.7
1.97
143
329
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
299
1239
3.97
58.31
2.0
2.1
mg/l
3.1
3.1
0.07
249
1063
(40768804) Tissue Pathology biopsy report
384
1891
4.16
57.89
2.8
2.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
256
968
3.99
56.79
8.9
3.2
mmol/l
2.5
2.5
1.19
241
855
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
140
336
5.20
56.61
10.7
9.4
%
1.1
1.4
3.04
140
330
(3014111) Lactate [Moles/volume] in Serum or Plasma
165
458
4.66
55.78
9.1
7.4
mmol/l
1.1
1.4
2.21
165
438
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
126
281
5.47
55.37
9.3
10.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
366
1932
3.50
45.51
2.5
2.7
ug/l
88.7
145.9
4.38
350
1759
(3016502) Oxygen saturation in Arterial blood
167
555
3.84
43.08
10.4
8.1
%
96.3
95.6
0.63
167
530
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
437
2637
3.82
42.60
13.6
6.7
umol/l
11.2
11.7
0.63
423
2499
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
148
461
3.99
41.80
3.1
2.3
u/l
32.4
34.4
0.24
130
397
(3015377) Calcium [Moles/volume] in Serum or Plasma
325
1715
3.08
38.13
9.2
3.6
mmol/l
2.4
2.3
2.80
311
1496
(3003396) Base excess in Arterial blood by calculation
169
611
3.51
37.85
10.3
7.9
mmol/l
-0.5
1.3
7.28
156
485
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
169
612
3.50
37.75
9.9
7.9
kpa
5.2
5.1
0.14
169
586
(3027801) Oxygen [Partial pressure] in Arterial blood
169
612
3.50
37.75
9.9
7.9
kpa
14.5
12.1
5.84
169
589
(3003694) ABO and Rh group [Type] in Blood
259
1217
3.07
37.19
1.3
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
300
1553
2.97
35.77
3.5
3.3
e6/l
86.4
108.0
0.14
207
1210
(3030467) Casts [#/volume] in Urine by Automated count
283
1430
2.94
35.12
3.4
3.2
e6/l
0.6
0.5
0.20
198
1075
(36304419) Bacteria [Presence] in Urine
276
1379
2.94
34.92
3.4
3.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
431
2763
3.30
34.12
14.6
9.7
e9/l
3.8
4.1
2.31
334
2424
(3013826) Glucose [Moles/volume] in Serum or Plasma
440
2904
3.26
32.09
7.4
5.0
mmol/l
6.7
6.8
0.30
431
2732
(3018095) Leukocytes [#/volume] in Urine
318
1783
2.77
31.27
4.2
3.8
e6/l
116.8
75.6
0.45
214
1299
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
191
833
2.94
30.26
3.1
3.0
e6/l
2.1
2.1
0.02
90
466
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
149
576
3.15
29.11
5.1
2.8
umol/l
7.0
8.8
0.83
135
508
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
196
888
2.84
28.70
3.0
2.8
e6/l
0.8
1.1
0.49
95
516
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
318
1840
2.65
28.48
3.4
3.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
505
3826
3.81
25.20
14.4
7.9
u/l
82.0
80.1
0.44
486
3575
(40758558) Short blood count panel - Blood
230
1203
2.53
24.52
12.4
7.6
—
—
—
0
0
(3044889) 12 lead EKG panel
470
3493
2.97
22.60
4.6
4.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
122
482
2.95
22.45
2.6
2.3
g/l
0.2
0.2
0.89
115
450
(3023368) Bacteria identified in Blood by Culture
254
1448
2.36
21.76
4.9
4.6
—
—
—
0
0
(4035726)
117
460
2.94
21.66
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
148
660
2.68
21.56
1.3
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
365
2498
2.28
19.41
8.9
7.0
mmol/l
1.2
1.2
8.97
333
2122
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
554
4702
7.35
18.76
27.7
15.8
mg/l
38.3
25.4
12.88
526
3786
(3018418) pH of Serum or Plasma
254
1531
2.19
18.18
3.7
4.2
ph
7.4
7.4
0.47
34
292
(3020779) Urea [Moles/volume] in Serum or Plasma
108
448
2.74
17.87
6.8
7.5
mmol/l
8.4
10.3
1.79
103
424
(3009542) Hematocrit [Volume Fraction] of Blood
513
4199
3.22
16.92
35.4
16.9
%
38.8
39.8
2.54
427
2858
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
536
4524
4.10
16.37
28.1
14.9
ml/min/173m2
79.7
77.2
2.29
459
3777
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
334
2299
2.09
16.27
8.6
6.2
mmol/l
1.2
1.2
8.00
325
2078
(3026782) Osmolality of Urine
183
1015
2.18
15.70
3.0
2.9
mosm/kgh2o
559.3
554.7
0.09
146
863
(3037121) Protein [Mass/volume] in Urine
54
167
3.47
14.76
5.4
3.3
g/l
0.2
0.2
0.05
42
66
(3021589) Normoblasts [#/volume] in Blood
305
2115
1.95
13.61
11.7
10.3
e9/l
0.0
0.0
0.40
212
1745
(3000850) Epithelial cells [#/volume] in Urine
185
1081
2.05
13.51
2.6
2.6
e6/l
6.0
4.5
0.83
155
956
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
169
977
2.04
12.58
3.7
3.9
ng/l
227.6
362.1
0.46
141
810
(3012095) Magnesium [Moles/volume] in Serum or Plasma
148
836
2.04
11.62
4.6
3.5
mmol/l
0.8
0.8
0.50
135
785
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
82
365
2.46
11.52
1.5
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
299
2151
1.82
11.05
9.0
9.7
inr
1.2
1.3
0.51
79
617
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
13
633
0.19
10.20
4.4
4.8
%
39.9
31.5
—
7
411
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
185
2.87
10.12
3.2
2.4
u/ml
0.3
0.3
1.35
31
94
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
228
1563
1.76
9.50
4.5
3.4
u/l
40.5
32.9
1.20
217
1490
(40768441) Liver Pathology biopsy report
21
46
4.70
9.13
1.2
1.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
303
2273
1.71
8.97
5.2
6.2
%
24.7
26.9
2.33
286
2123
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
553
5060
4.11
8.86
17.8
11.1
u/l
25.5
26.0
0.30
546
4874
(42870588) Differential panel, method unspecified - Blood
232
1624
1.72
8.81
4.8
5.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
93
488
2.08
8.74
2.0
2.2
ug/g
300.3
143.3
2.07
73
399
(3018010) Neutrophils/100 leukocytes in Blood
298
2238
1.69
8.69
5.1
5.9
%
60.5
57.8
3.23
282
2102
(3022096) Basophils/100 leukocytes in Blood
290
2171
1.68
8.48
5.2
6.0
%
0.6
0.7
2.36
272
2030
(3019069) Monocytes/100 leukocytes in Blood
297
2239
1.68
8.45
5.2
6.3
%
8.8
8.8
0.10
280
2103
(3006504) Eosinophils/100 leukocytes in Blood
295
2229
1.67
8.25
5.2
6.0
%
2.8
2.9
0.27
280
2081
(3007461) Platelets [#/volume] in Blood
560
5206
5.31
7.94
40.4
23.1
e9/l
248.1
243.8
0.85
542
5072
(3026361) Erythrocytes [#/volume] in Blood
560
5207
5.30
7.91
40.4
23.1
e12/l
4.4
4.5
3.87
540
5055
(3010813) Leukocytes [#/volume] in Blood
560
5207
5.30
7.91
40.4
23.1
e9/l
6.9
6.7
0.85
541
5053
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
67
325
2.20
7.67
1.5
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
310
2420
1.62
7.26
5.2
5.9
e9/l
2.2
1.9
0.23
241
2118
(3038177) Helicobacter pylori Ab [Presence] in Serum
20
52
3.95
7.04
1.3
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
102
597
1.86
6.93
1.8
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
102
601
1.85
6.78
1.8
2.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
303
2384
1.58
6.63
5.1
5.8
e9/l
0.6
0.6
0.01
225
2042
(3024928) Oxygen saturation in Venous blood
31
112
2.87
6.58
2.0
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
392
3286
1.62
6.46
4.7
4.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
303
2396
1.56
6.40
5.1
5.8
e9/l
0.0
0.0
1.15
224
2060
(40761511) CBC panel - Blood by Automated count
534
4904
2.41
6.40
19.8
14.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
205
1483
1.60
6.37
3.7
3.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
318
2548
1.56
6.29
2.7
2.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
37
152
2.53
6.16
5.4
3.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
14
31
4.60
6.01
2.0
2.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
15
36
4.25
5.85
2.1
1.5
%
10.8
10.2
0.20
15
36
(3021447) Carbon dioxide [Partial pressure] in Venous blood
84
487
1.85
5.85
3.2
3.5
kpa
5.5
5.8
2.47
79
469
(3011397) Hemoglobin [Presence] in Urine by Test strip
159
1106
1.61
5.72
3.2
3.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
305
2467
1.51
5.47
5.3
6.1
e9/l
0.2
0.2
0.42
238
2161
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
35
149
2.44
5.43
1.8
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
95
592
1.73
5.18
1.9
2.5
%
1.7
1.8
0.27
82
532
(3002032) Base excess in Venous blood by calculation
81
482
1.79
5.18
3.3
3.5
mmol/l
0.6
2.0
2.19
68
386
(3019225) pH of Specimen
18
494
0.34
5.17
5.4
4.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
114
761
1.62
4.78
2.5
2.1
—
—
—
0
0
(3013512) EKG study
110
1556
0.64
4.33
4.1
4.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
10
22
4.61
4.32
3.2
2.8
%
107.1
90.8
—
10
22
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
259
2094
1.43
4.28
2.0
2.0
pmol/l
89.2
94.8
1.27
140
1069
(36660697) Celiac disease serology panel - Serum
54
301
1.88
4.26
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
33
640
0.49
4.07
15.8
7.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
160
1196
1.47
3.96
2.9
3.1
ug/l
0.8
0.8
0.38
113
817
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
17
59
2.94
3.93
1.2
1.1
g/l
1.6
1.6
0.17
17
52
(3007164) IgA [Mass/volume] in Serum or Plasma
121
857
1.52
3.88
1.4
1.4
g/l
2.2
2.7
2.19
54
514
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
31
146
2.19
3.88
1.1
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
16
54
3.02
3.87
4.8
3.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
100
682
1.57
3.80
4.4
5.6
mmol/l
1.0
1.0
0.22
94
631
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
134
2.23
3.80
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
136
2.19
3.67
1.1
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
67
417
1.69
3.67
2.9
2.8
kpa
4.5
4.5
0.04
62
400
(3051651) Icteric interference index of Serum or Plasma
12
37
3.29
3.36
5.1
3.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
353
3093
1.37
3.27
3.7
3.2
u/l
55.8
53.0
0.17
326
2867
(3025941) Bacteria identified in Stool by Culture
44
251
1.82
3.27
1.2
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
251
0.35
3.25
4.7
3.6
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
12
38
3.20
3.23
1.0
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
25
118
2.17
3.15
1.2
1.1
—
45.0
—
0
6
(3003327) Ova and parasites identified in Stool by Light microscopy
26
126
2.11
3.07
1.6
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
7
209
0.33
2.99
5.3
4.1
mmol/l
24.3
25.0
—
7
196
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
101
2.23
2.97
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
101
2.23
2.97
1.1
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
27
135
2.05
2.95
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
36
200
1.85
2.93
1.2
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
113
835
1.44
2.90
1.9
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
83
579
1.51
2.85
2.0
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
165
2036
0.73
2.84
4.0
3.9
ng/l
39.4
59.7
0.56
119
1525
(3021601) Nitrite [Presence] in Urine by Test strip
274
2350
1.32
2.73
5.8
5.1
estimate
0.0
0.0
0.00
46
454
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
195
1595
1.34
2.70
2.7
2.5
u/l
54.8
56.8
0.23
182
1465
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
43
261
1.70
2.63
2.3
2.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
137
1069
1.37
2.56
1.9
1.7
mg/l
1.7
1.3
0.71
113
839
(3019150) Specific gravity of Urine by Refractometry
74
1025
0.68
2.48
3.7
4.2
kg/l
1.0
1.0
—
5
135
(3009261) Glucose [Presence] in Urine by Test strip
275
2382
1.30
2.47
3.9
3.8
estimate
0.0
0.0
0.50
43
442
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
121
933
1.38
2.43
1.3
1.2
u/ml
4.2
1.3
0.94
31
259
(3000492) Spirometry study
65
451
1.50
2.31
1.5
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
38
234
1.67
2.23
1.3
1.9
g/l
1.8
1.6
0.98
30
203
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
151
1.83
2.20
1.5
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
24
3.37
2.18
1.5
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
163
1340
1.30
2.11
1.6
1.7
mmol/l
1.4
1.4
0.31
146
1110
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
495
4700
1.40
2.02
4.7
4.9
mmol/l
6.1
6.0
0.33
466
4268
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
26
3.11
2.02
1.1
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
26
3.11
2.02
1.1
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
82
1076
0.72
2.00
1.7
1.8
pmol/l
445.5
24201355.6
0.94
71
876
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
508
4848
1.44
1.98
5.1
5.3
mmol/l
2.7
2.7
0.07
477
4423
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
255
0.46
1.98
1.2
1.2
—
130.2
—
0
92
(3035350) Ketones [Presence] in Urine by Test strip
266
2347
1.25
1.89
3.9
3.8
estimate
0.0
0.0
0.00
44
455
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
13
59
2.23
1.85
1.1
1.4
nmol/l
0.8
0.6
0.81
13
53
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
68
502
1.40
1.78
1.6
1.7
%
1.5
1.5
0.18
59
418
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
18
3.36
1.75
3.0
2.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
105
1298
0.77
1.70
4.5
4.2
estimate
0.0
0.0
0.50
41
440
(40768793) Breast Pathology biopsy report
19
104
1.86
1.69
1.5
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
8
31
2.60
1.66
1.4
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
190
0.47
1.64
1.9
1.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
56
2.17
1.62
1.1
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
21
347
0.59
1.59
3.4
3.5
ph
7.4
7.4
—
7
44
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
181
0.49
1.53
1.8
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
44
0.00
1.52
0.0
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
21
2.88
1.51
1.3
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
45
0.00
1.50
0.0
2.5
—
605.5
—
0
30
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
72
1.97
1.50
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
29
2.43
1.39
1.7
4.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
58
756
0.74
1.37
1.4
1.3
u/ml
15.4
12.9
0.07
21
293
(3001893) Eosinophils/100 leukocytes in Pleural fluid
6
23
2.63
1.37
1.2
1.4
%
1.7
2.6
—
6
16
(40768443) Skin Pathology biopsy report
33
224
1.50
1.37
1.3
1.2
—
—
—
0
0
(4281824)
10
47
2.15
1.34
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
39
0.00
1.34
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
39
0.00
1.34
0.0
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
39
0.00
1.34
0.0
1.0
—
579.1
—
0
22
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
39
0.00
1.34
0.0
1.0
—
226.6
—
0
22
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
39
0.00
1.34
0.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
39
0.00
1.34
0.0
1.0
—
30.9
—
0
20
(3025577) Chromium [Mass/volume] in Blood
0
39
0.00
1.34
0.0
2.3
—
2.1
—
0
33
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
40
0.00
1.33
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
40
0.00
1.33
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
40
0.00
1.33
0.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
132
0.45
1.30
1.0
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
74
586
1.30
1.27
3.2
4.3
u/l
243.7
260.5
0.28
69
554
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
35
2.30
1.27
1.4
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
60
463
1.33
1.24
2.4
2.5
e9/l
74.1
69.9
0.27
32
361
(40761535) Cells panel - Urine sediment
30
429
0.68
1.23
2.7
3.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
19
2.65
1.22
1.0
3.1
u/l
167.2
219.3
—
5
19
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
327
1.37
1.16
1.3
1.5
—
—
—
0
0
(3016750) Collection duration of Urine
0
33
0.00
1.16
0.0
2.6
—
508.8
—
0
24
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
222
0.58
1.16
1.5
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
20
2.51
1.15
1.2
1.2
iu/ml
409.0
166.6
—
5
20
(3017704) Immunofixation for Urine
0
36
0.00
1.14
0.0
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
193
1.47
1.11
2.6
2.5
g/l
3.2
3.2
0.05
21
151
(3008898) HLA-B27 [Presence]
7
138
0.50
1.11
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
57
446
1.31
1.09
1.3
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
32
2.20
1.08
2.3
4.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
65
804
0.78
1.07
1.4
1.3
iu/ml
19.3
35.2
1.04
23
257
(3000494) Fungus identified in Specimen by Culture
76
620
1.26
1.06
1.7
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
130
1.56
1.04
2.1
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
22
2.28
1.03
1.0
1.4
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
5
22
2.28
1.03
1.2
1.3
%
27.5
35.5
—
5
17
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
22
2.28
1.03
7.0
6.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
22
2.28
1.03
2.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
106
0.47
1.02
1.8
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
55
433
1.30
1.02
1.3
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
53
1.90
1.02
1.1
1.4
nmol/l
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
23
2.18
0.98
1.0
1.4
%
63.0
56.5
—
5
16
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
30
0.00
0.97
0.0
2.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
7
36
1.96
0.97
1.1
1.5
—
28.6
—
0
5
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
181
1622
1.17
0.97
2.6
3.0
ng/l
1070.0
1217.4
0.40
160
1398
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
67
545
1.26
0.97
4.2
3.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
37
277
1.36
0.96
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
117
1.56
0.94
1.1
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
82
685
1.23
0.94
31.5
25.1
inr
1.3
1.3
0.00
13
89
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
209
1.41
0.94
2.6
2.4
g/l
3.8
3.8
0.03
21
149
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
209
1.41
0.94
2.6
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
209
1.41
0.94
2.6
2.4
g/l
8.2
7.5
1.35
22
157
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
3.3
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
3.3
1.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
63
1.76
0.90
4.4
4.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
103
0.48
0.90
1.2
1.2
—
9.4
—
0
11
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
152
0.59
0.90
1.2
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
22
311
0.70
0.89
6.1
3.1
e9/l
4.1
4.1
0.01
22
231
(1616796) Gas panel - Central venous blood
17
111
1.55
0.88
2.8
3.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
185
1672
1.16
0.88
3.8
4.4
%
23.4
21.3
1.18
84
819
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
27
195
1.40
0.88
2.7
2.5
g/l
11.1
10.5
0.15
22
166
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
96
1.58
0.85
1.5
1.3
—
—
—
0
0
(4306422)
10
57
1.77
0.84
1.2
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
6
32
1.88
0.82
1.0
1.2
u/field
0.8
3.1
—
6
23
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
448
4322
1.17
0.81
4.3
4.6
mu/l
3.7
2.2
0.38
411
3904
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
25
181
1.40
0.81
2.7
2.8
g/l
2.5
1.1
0.38
20
159
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
60
495
1.24
0.79
1.4
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
24
0.00
0.79
0.0
2.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.6
—
1.0
—
0
18
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.1
—
2.0
—
0
25
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
488
4745
1.20
0.79
4.3
4.8
mmol/l
4.6
4.6
0.38
453
4354
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
100
0.50
0.78
1.4
1.2
—
38.3
—
0
8
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
27
0.00
0.77
0.0
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
27
0.00
0.77
0.0
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
27
0.00
0.77
0.0
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
27
0.00
0.77
0.0
1.9
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
27
201
1.36
0.76
5.6
4.0
mmol/l
1.7
1.5
0.23
27
194
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
24
2.09
0.74
1.2
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
8
134
0.59
0.74
1.3
1.3
—
29.7
—
0
5
(3001019) Free T4 and TSH panel - Serum or Plasma
25
185
1.37
0.73
1.6
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
25
2.01
0.73
1.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
57
1.59
0.71
1.1
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
52
429
1.23
0.70
1.8
3.1
ng/l
236.5
194.3
0.28
47
390
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
157
0.63
0.70
1.4
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
80
690
1.19
0.69
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
59
1.53
0.68
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
27
1.86
0.68
1.6
1.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
119
1.44
0.67
2.0
2.2
g/l
124.7
128.2
0.14
11
92
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
43
1.64
0.67
3.1
1.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
41
332
1.25
0.66
2.1
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
129
0.61
0.64
1.3
1.2
—
2.2
—
0
21
(3000330) Specific gravity of Urine by Test strip
32
252
1.29
0.64
6.3
3.8
—
—
—
0
0
(4034850)
11
165
0.66
0.64
8.5
11.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
176
1621
1.12
0.62
3.0
3.1
mmol/l
7.7
7.6
0.09
155
1341
(40768795) Lymph node Pathology biopsy report
8
49
1.64
0.62
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
105
0.57
0.62
1.0
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
63
1.60
0.62
2.5
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
5
30
1.67
0.61
1.2
1.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
2.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
21
0.00
0.60
0.0
2.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
52
1.55
0.59
1.6
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
30
237
1.28
0.59
2.3
2.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
483
4719
1.15
0.58
4.2
4.7
mmol/l
1.4
1.4
1.07
444
4297
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
241
0.74
0.58
1.4
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
139
1269
1.13
0.57
1.5
1.5
nmol/l
20.1
20.6
0.17
128
1069
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
36
1.67
0.57
1.0
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
36
1.67
0.57
3.3
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
186
1.30
0.55
1.0
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
126
0.63
0.55
1.3
1.2
—
2.7
—
0
17
(3011985) Renin [Units/volume] in Plasma
9
62
1.46
0.53
1.1
1.4
mu/l
44.6
33.3
—
9
57
(3019832) Treponema pallidum Ab [Presence] in Serum
12
169
0.70
0.52
1.4
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
99
0.60
0.52
1.2
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
40
1.51
0.51
1.5
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
218
2053
1.10
0.50
4.8
5.2
ug/l
2.6
3.0
0.33
191
1830
(1002224) Polysomnography panel
24
190
1.27
0.48
1.1
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
46
1.53
0.48
2.1
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
60
527
1.15
0.45
1.3
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
18
139
1.30
0.44
8.2
5.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
367
3557
1.09
0.43
3.7
4.3
mm/h
16.6
13.0
2.78
338
3267
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
33
1.52
0.41
1.6
1.7
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(4015189)
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
16
0.00
0.41
0.0
1.4
—
23.6
—
0
11
(3037522) Nuclear Ab [Titer] in Serum
53
601
0.87
0.41
1.3
1.3
titre
205.7
491.3
—
7
141
(44806420)
0
17
0.00
0.40
0.0
2.5
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
17
0.00
0.40
0.0
1.1
—
2.1
—
0
17
(3020630) Protein [Mass/volume] in Serum or Plasma
52
457
1.15
0.40
2.3
2.8
g/l
65.3
66.7
0.54
46
413
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
61
1.32
0.39
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
19
0.00
0.39
0.0
1.1
—
1.1
—
0
5
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
8
112
0.71
0.37
1.1
1.2
mg/l
528.5
511.8
—
8
104
(3047181) Lactate [Moles/volume] in Blood
12
158
0.75
0.37
15.2
6.9
mmol/l
1.4
1.3
0.17
12
139
(3014051) Protein [Presence] in Urine by Test strip
14
107
1.32
0.37
4.3
2.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
78
0.64
0.36
1.0
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
80
0.62
0.35
1.2
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
80
0.62
0.35
1.2
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
204
1945
1.08
0.35
2.1
2.3
nmol/l
77.1
78.1
0.18
191
1723
(3012516) Albumin [Mass/volume] in Urine
168
1590
1.08
0.34
3.1
3.2
mg/l
446.5
287.5
0.17
105
1024
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47
416
1.14
0.34
5.0
4.4
mmol/l
1.2
1.2
0.15
42
369
(4062490)
6
47
1.28
0.32
1.5
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
17
137
1.25
0.32
1.8
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
92
1.31
0.32
3.5
3.4
%
51.3
58.9
1.23
12
92
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
110
1.28
0.32
1.0
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
99
0.70
0.31
1.0
1.2
mmol/l
3.9
3.9
—
7
91
(3045788) Cell count panel - Pleural fluid
7
53
1.32
0.31
2.0
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
43
382
1.14
0.30
2.5
2.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
14
111
1.27
0.30
4.5
3.9
mmol/l
2.2
2.4
—
9
75
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
111
1.27
0.30
1.6
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
259
0.84
0.29
1.4
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
15
121
1.25
0.28
2.8
2.5
%
16.2
15.9
—
9
65
(1761868) Lipid panel - Serum or Plasma
157
1648
0.93
0.28
3.0
3.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
8
62
1.29
0.28
1.1
1.1
—
20.5
—
0
13
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
64
1.25
0.27
2.0
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
104
1.26
0.26
2.2
2.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
86
1.28
0.26
1.1
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
345
3528
0.94
0.26
3.5
3.8
pmol/l
14.8
14.9
0.33
315
3157
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
64
589
1.10
0.26
1.5
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
463
4566
1.07
0.25
3.8
4.2
mmol/l
1.3
1.3
0.28
416
4141
(3003434) Protein [Mass/volume] in Pleural fluid
9
73
1.24
0.25
1.4
1.6
g/l
32.8
30.6
—
9
64
(3020682) Albumin/Creatinine [Ratio] in Urine
175
1678
1.06
0.25
4.0
4.0
mg/mmol
14.9
8.5
0.49
115
1068
(3034860) Kappa light chains.free [Mass/volume] in Serum
21
179
1.18
0.25
1.9
3.9
mg/l
80.0
87.0
0.05
14
145
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
21
179
1.18
0.25
1.8
3.9
mg/l
42.2
33.7
0.40
14
145
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
283
1.14
0.25
1.2
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
13
158
0.82
0.24
1.5
1.4
g/l
1.2
1.2
0.48
13
152
(3039443) Prostate specific Ag panel - Serum or Plasma
14
115
1.22
0.23
1.6
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
91
0.77
0.22
1.3
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
46
420
1.10
0.22
4.7
3.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
134
1281
1.06
0.22
3.9
3.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
5
42
1.19
0.21
1.0
1.1
nmol/l
430.2
384.9
—
5
35
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
10
0.00
0.21
0.0
1.8
—
1.3
—
0
10
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
1668.5
—
0
10
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
459
4534
1.06
0.21
5.8
6.2
mmol/mol
39.9
40.5
0.67
433
4192
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
2.7
—
0
5
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
0.8
—
0
7
(3032057) Clostridioides difficile [Presence] in Stool
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
80
1.25
0.20
2.5
1.8
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
90
1.23
0.19
3.2
2.9
e9/l
3.5
4.5
0.82
11
90
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
53
1.13
0.18
2.0
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
103
982
1.06
0.18
1.6
1.7
nmol/l
1207.4
1214.6
0.02
72
737
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
52
484
1.08
0.18
1.5
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
98
1026
0.95
0.17
5.5
4.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
62
1.13
0.17
1.0
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
20
177
1.13
0.16
1.8
3.8
—
2.1
—
0
16
(3000764) Benzodiazepines [Presence] in Urine
8
71
1.13
0.16
1.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
71
1.13
0.16
3.3
3.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
72
1.11
0.16
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
72
1.11
0.16
1.0
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
8
72
1.11
0.16
2.3
1.8
%
84.7
89.7
—
8
72
(3027944) Amphetamines [Presence] in Urine
8
72
1.11
0.16
1.0
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
80
0.75
0.15
1.0
2.9
—
792.1
—
0
8
(3039000) Anion gap in Blood
10
119
0.84
0.15
17.5
7.0
mmol/l
10.7
11.1
—
10
107
(3018572) Chloride [Moles/volume] in Blood
10
119
0.84
0.15
17.5
7.0
mmol/l
107.4
105.8
—
10
107
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
81
1.11
0.15
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
129
0.85
0.15
2.4
1.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
129
0.85
0.15
1.0
1.6
—
—
—
0
0
(4010399)
35
377
0.92
0.14
1.5
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
97
0.82
0.14
2.8
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
8
100
0.80
0.13
1.3
1.5
—
5.2
—
0
34
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
106
0.85
0.13
1.3
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
108
0.83
0.13
1.4
1.9
pmol/l
185.4
232.1
—
9
97
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
50
473
1.06
0.12
2.5
2.6
ug/l
4.0
8.1
2.87
44
418
(3043409) Potassium [Moles/volume] in Arterial blood
19
172
1.11
0.11
7.1
3.8
mmol/l
3.7
3.9
2.05
19
159
(3021440) Promyelocytes/100 leukocytes in Blood
42
397
1.06
0.11
5.4
4.4
%
0.0
0.2
4.18
13
128
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
44
1.14
0.10
2.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
22
203
1.09
0.09
3.1
1.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
46
1.09
0.09
2.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
34
360
0.94
0.09
9.6
4.7
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
48
1.04
0.09
1.4
1.1
nmol/l
0.9
1.7
—
5
43
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
179
1823
0.97
0.09
4.1
4.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
40
380
1.06
0.09
4.9
4.2
%
0.9
0.5
—
10
102
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
57
1.05
0.08
1.7
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
195
0.92
0.08
1.6
3.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
67
1.05
0.08
1.0
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
39
372
1.05
0.08
5.7
4.5
%
0.0
0.1
—
10
106
(3036481) Cortisol [Moles/volume] in Serum or Plasma
47
451
1.05
0.07
1.9
2.0
nmol/l
348.6
372.9
0.15
41
417
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
76
1.05
0.07
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
81
0.86
0.07
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
82
0.85
0.07
4.0
2.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
83
0.84
0.07
3.0
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
85
0.82
0.07
1.9
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
87
1.04
0.07
1.7
1.5
mu/l
325.3
264.4
—
9
80
(3017446) Testosterone [Moles/volume] in Serum or Plasma
39
407
0.96
0.07
1.9
2.3
nmol/l
12.6
13.4
0.34
33
351
(21494755) Public health laboratory ask at order entry panel
37
355
1.05
0.06
1.4
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
44
425
1.04
0.05
5.3
4.3
%
1.1
1.0
0.10
15
143
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
110
0.91
0.05
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
43
417
1.03
0.04
3.9
2.8
ml/min/173m2
72.4
63.0
0.76
15
167
(40760888) Immunoglobulin light chains.free panel - Serum
14
132
1.06
0.02
1.6
4.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
93
1.08
0.02
2.5
1.9
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13
137
0.95
0.01
1.5
1.8
nmol/l
39.0
41.9
0.23
13
131
(3022621) pH of Urine by Test strip
30
307
0.98
0.01
3.6
2.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
126
0.95
0.00
1.4
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
155
1557
0.99
0.00
2.1
2.2
u/l
183.4
237.2
0.38
145
1471
(3015171) Extractable nuclear Ab [Units/volume] in Serum
16
166
0.96
0.00
1.4
1.2
—
2.8
—
0
10
(4094501)
15
145
1.04
0.00
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
124
0.97
0.00
2.3
1.9
—
—
—
0
0
(3020891) Body temperature
22
217
1.01
0.00
7.2
4.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
223
0.99
0.00
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
112
0.98
0.00
1.5
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
14
139
1.01
0.00
1.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
135
1351
1.00
0.00
2.5
2.8
umol/l
14531.2
6575.7
0.64
115
1168
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
74
0.95
0.00
1.3
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
79
1.01
0.00
2.8
1.7
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.2
—
0.3
—
0
5
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
73
0.96
0.00
3.0
1.8
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
12.4
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
89
0.90
0.00
1.3
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
82
0.98
0.00
3.5
2.9
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
95.4
—
0
7
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
2.2
—
0
8
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
64
0.94
0.00
1.8
1.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
93
0.97
0.00
3.7
3.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
64
0.94
0.00
1.8
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
8
0.00
0.00
0.0
5.6
—
6.1
—
0
8
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.2
—
0
8
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
5.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
75
0.93
0.00
1.1
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
64
0.94
0.00
1.8
1.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
63
0.95
0.00
1.8
1.5
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
8.5
—
0
5
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
50
1.00
0.00
1.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
58
0.86
0.00
1.0
2.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
63
0.95
0.00
1.8
1.5
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
65.2
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
54
0.93
0.00
2.0
2.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
62
0.97
0.00
1.8
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: OPER_JFB44 – Laparoscopic left hemicolectomy

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).